Baillie Gifford & CO Insulet Corp Transaction History
Baillie Gifford & CO
- $126 Billion
- Q2 2024
A detailed history of Baillie Gifford & CO transactions in Insulet Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 1,886,062 shares of PODD stock, worth $437 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
1,886,062
Previous 1,442,279
30.77%
Holding current value
$437 Million
Previous $247 Million
53.96%
% of portfolio
0.3%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding PODD
# of Institutions
659Shares Held
63.5MCall Options Held
385KPut Options Held
773K-
Vanguard Group Inc Valley Forge, PA8.4MShares$1.95 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$1.66 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.41 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.86MShares$663 Million0.03% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.74MShares$405 Million0.1% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $16.1B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...